Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants EUAs for Labcorp Respiratory Panel, Nexus Medical COVID-19 Test

NEW YORK — The US Food and Drug Administration this week granted separate Emergency Use Authorizations for a respiratory panel RT-PCR test from Laboratory Corporation of America and a COVID-19 RT-PCR test from Nexus Medical Labs.

The Labcorp Seasonal Respiratory Virus RT-PCR Test is designed for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza viruses A and B, and respiratory syncytial virus RNA in nasopharyngeal, mid-turbinate, and anterior nasal swab specimens. The test may also be used with individual anterior nasal swab specimens collected at home using the Labcorp COVID-19+Flu+RSV Test Home Collection Kit.

The test may only be performed at the Center for Esoteric Testing or other labs designated by Labcorp that are CLIA-certified to perform high-complexity tests, according to the FDA.

Earlier this month, Burlington, North Carolina-based Labcorp received EUA from the FDA for a nonprescription version of the Seasonal Respiratory Virus Test.

The Nexus High Throughput SARS-CoV-2 Assay is designed for the qualitative detection of SARS-CoV-2 nucleic acid in anterior nasal swab specimens that are collected using the Rhinostics Nasal Swab Collection Kit either at home or in a healthcare setting.

Use of the test is limited to Aldatu Diagnostics, the FDA said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.